Temporal Change in Renoprotective Effect of Tolvaptan on Patients with Heart Failure: AURORA Study

(1) Background: It has been reported that tolvaptan (TLV) has a renoprotective effect in acute decompensated heart failure (ADHF) patients, but whether this effect is continued for a long time is unclear. Thus, we evaluated the time course of the renoprotective effect of TLV, in addition to the prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishino, Masami, Egami, Yasuyuki, Tanaka, Akihiro, Kawanami, Shodai, Sugae, Hiroki, Ukita, Kohei, Kawamura, Akito, Nakamura, Hitoshi, Matsuhiro, Yutaka, Yasumoto, Koji, Tsuda, Masaki, Okamoto, Naotaka, Matsunaga-Lee, Yasuharu, Yano, Masamichi, Tanouchi, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879381/
https://www.ncbi.nlm.nih.gov/pubmed/35207249
http://dx.doi.org/10.3390/jcm11040977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879381/
https://www.ncbi.nlm.nih.gov/pubmed/35207249
http://dx.doi.org/10.3390/jcm11040977

Ejemplares similares